FI940951A0 - Förfarande för framställning av parenteral antibakterisk sammansättning - Google Patents

Förfarande för framställning av parenteral antibakterisk sammansättning

Info

Publication number
FI940951A0
FI940951A0 FI940951A FI940951A FI940951A0 FI 940951 A0 FI940951 A0 FI 940951A0 FI 940951 A FI940951 A FI 940951A FI 940951 A FI940951 A FI 940951A FI 940951 A0 FI940951 A0 FI 940951A0
Authority
FI
Finland
Prior art keywords
preparation
antibacterial composition
stands
hydrogen
parenteral
Prior art date
Application number
FI940951A
Other languages
English (en)
Finnish (fi)
Other versions
FI104045B (sv
FI104045B1 (sv
FI940951A (sv
Inventor
Tomoyuki Iwahi
Hiroshi Satoh
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26370930&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI940951(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of FI940951A publication Critical patent/FI940951A/sv
Publication of FI940951A0 publication Critical patent/FI940951A0/sv
Application granted granted Critical
Publication of FI104045B publication Critical patent/FI104045B/sv
Publication of FI104045B1 publication Critical patent/FI104045B1/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
FI940951A 1989-02-10 1994-02-28 Förfarande för framställning av parenteral antibakterisk sammansättning FI104045B1 (sv)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP3237489 1989-02-10
JP3237489 1989-02-10
JP23923389 1989-09-15
JP23923389 1989-09-15
FI900662A FI100168B (sv) 1989-02-10 1990-02-09 Förfarande för framställning av ett oralt doserbart farmaceutiskt prep arat
FI900662 1990-02-09

Publications (4)

Publication Number Publication Date
FI940951A FI940951A (sv) 1994-02-28
FI940951A0 true FI940951A0 (sv) 1994-02-28
FI104045B FI104045B (sv) 1999-11-15
FI104045B1 FI104045B1 (sv) 1999-11-15

Family

ID=26370930

Family Applications (2)

Application Number Title Priority Date Filing Date
FI900662A FI100168B (sv) 1989-02-10 1990-02-09 Förfarande för framställning av ett oralt doserbart farmaceutiskt prep arat
FI940951A FI104045B1 (sv) 1989-02-10 1994-02-28 Förfarande för framställning av parenteral antibakterisk sammansättning

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI900662A FI100168B (sv) 1989-02-10 1990-02-09 Förfarande för framställning av ett oralt doserbart farmaceutiskt prep arat

Country Status (10)

Country Link
US (1) US5013743A (sv)
EP (1) EP0382489B1 (sv)
AT (1) ATE114114T1 (sv)
CA (1) CA2009741C (sv)
DE (1) DE69014141T2 (sv)
DK (1) DK0382489T3 (sv)
ES (1) ES2066120T3 (sv)
FI (2) FI100168B (sv)
GR (1) GR3014973T3 (sv)
NO (1) NO900639L (sv)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338723A (en) * 1989-10-13 1994-08-16 Merck & Co., Inc. Fibrinogen receptor antagonists
JPH06500547A (ja) * 1990-09-14 1994-01-20 ビイク　グルデン　ロンベルク　ヒエーミツシエ　フアブリーク　ゲゼルシヤフト　ミツト　ベシユレンクテル　ハフツング ピリジルメチルスルフィニル―１ｈ―ベンゾイミダゾール誘導体のヘリコバクターにより起こされる病気の治療のための使用
TW209174B (sv) * 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
IS3990A (is) * 1992-04-24 1993-10-25 Ab Astra Aðferð við að blanda saman efni sem hindrar flæðimagasýru og bakteríueyðandi efnis sem brotnar niður í súru umhverfi
US5504082A (en) * 1992-06-01 1996-04-02 Yoshitomi Pharmaceutical Industries, Ltd. Pyridine compound and pharmaceutical compostions
PL307026A1 (en) * 1992-07-08 1995-05-02 Monsanto Co Method of producing ppaliative effect in respect to swine gastric ulcers
AU674015B2 (en) * 1992-07-28 1996-12-05 Astra Aktiebolag Injection and injection kit containing omeprazole and its analogs
ES2087623T3 (es) * 1992-08-21 1996-07-16 Eisai Co Ltd Derivados de bencimidazol como agente antimicrobiano contra campylobacter pylon.
AU5699594A (en) * 1992-12-10 1994-07-04 Byk Gulden Lomberg Chemische Fabrik Gmbh Use of alkylthiopyridines for controlling helicobacter bacteria
JPH06298611A (ja) * 1993-04-16 1994-10-25 Nippon Chemiphar Co Ltd 抗菌剤
DE59409645D1 (en) * 1993-06-29 2001-03-01 Byk Gulden Lomberg Chem Fab Substituierte arylthioalkylthiopyridine
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US6861448B2 (en) * 1998-01-14 2005-03-01 Virtual Drug Development, Inc. NAD synthetase inhibitors and uses thereof
EP1047692B1 (en) 1998-01-14 2004-07-21 The Uab Research Foundation Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof and methods of treating bacterial and microbial infections with these inhibitors
FI104384B (sv) 1998-06-05 2000-01-14 Valmet Corp Anläggning och förfarande för att blanda viravatten och färskmassa i en kanal efter virabrunnen
CA2419067C (en) * 2000-08-18 2008-12-23 Takeda Chemical Industries, Ltd. Injectable composition comprising benzimidazole compound and strong alkali
CN1243749C (zh) 2001-09-18 2006-03-01 泽里新药工业株式会社 苯并咪唑衍生物
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
JP2005521662A (ja) * 2002-01-25 2005-07-21 サンタラス インコーポレイティッド プロトンポンプ阻害剤の経粘膜送達
US8367111B2 (en) * 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US20040248942A1 (en) * 2003-02-20 2004-12-09 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
EP1648417A4 (en) * 2003-07-18 2010-01-20 Santarus Inc PHARMACEUTICAL FORMULATION AND METHOD FOR THE TREATMENT OF GASTROINTESTINAL ACIDITY RELATED DISORDERS
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
MXPA06000529A (es) * 2003-07-18 2006-08-11 Santarus Inc Formulaciones farmaceuticas utiles para inhibir la secrecion de acido y metodos para elaborarlas y utilizarlas.
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
EP1718303A4 (en) * 2004-02-10 2010-09-01 Santarus Inc COMBINATION OF INHIBITOR OF PROTON PUMP, BUFFER AND NON-STEROIDAL ANTI-INFLAMMATORY DRUG
CA2561700A1 (en) * 2004-04-16 2005-12-15 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and prokinetic agent
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20060024362A1 (en) 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
US8747895B2 (en) * 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ709754A (en) 2004-10-21 2017-02-24 Adare Pharmaceuticals Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
CN101309917B (zh) * 2005-10-06 2013-09-11 奥斯拜客斯制药有限公司 具有增强治疗性质的胃h+，k+-atp酶氘代抑制剂
PL2003130T3 (pl) * 2006-03-10 2012-04-30 Link Genomics Inc Nowa pochodna pirydyny o aktywności przeciwko helicobacter pylori
CA2654402A1 (en) * 2006-06-01 2007-12-06 Adel Penhasi Multiple unit pharmaceutical formulation
CA2654450A1 (en) * 2006-06-05 2007-12-13 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted erythromycin analogs
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
EP2068841B1 (en) 2006-10-05 2018-09-26 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
US20080103169A1 (en) 2006-10-27 2008-05-01 The Curators Of The University Of Missouri Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same
KR101353572B1 (ko) * 2009-04-09 2014-01-22 링크 제노믹스 가부시키가이샤 피리딘티오 유도체 및 이를 함유하는 항-헬리코박터피로리 작용을 가지는 의약 조성물
KR101765357B1 (ko) 2009-12-02 2017-08-04 아데어 파마수티컬스 에스.알.엘. 펙소페나딘 마이크로캡슐 및 그것을 함유하는 조성물
US20110212171A1 (en) * 2010-01-08 2011-09-01 Eurand, Inc. Taste masked topiramate composition and an orally disintegrating tablet comprising the same
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
JPS62277322A (ja) * 1986-02-13 1987-12-02 Takeda Chem Ind Ltd 安定化された腸溶性抗潰瘍固形組成物
JP2694361B2 (ja) * 1989-02-09 1997-12-24 アストラ アクチエボラグ 抗菌剤

Also Published As

Publication number Publication date
US5013743A (en) 1991-05-07
FI104045B (sv) 1999-11-15
DE69014141D1 (de) 1994-12-22
FI100168B (sv) 1997-10-15
DE69014141T2 (de) 1995-05-24
EP0382489B1 (en) 1994-11-17
EP0382489A2 (en) 1990-08-16
FI900662A0 (fi) 1990-02-09
EP0382489A3 (en) 1991-06-12
ES2066120T3 (es) 1995-03-01
CA2009741C (en) 1999-03-23
CA2009741A1 (en) 1990-08-10
FI104045B1 (sv) 1999-11-15
DK0382489T3 (da) 1995-01-16
GR3014973T3 (en) 1995-05-31
NO900639D0 (no) 1990-02-09
ATE114114T1 (de) 1994-12-15
FI940951A (sv) 1994-02-28
NO900639L (no) 1990-08-13

Similar Documents

Publication Publication Date Title
FI940951A0 (sv) Förfarande för framställning av parenteral antibakterisk sammansättning
NZ228893A (en) Substituted quinoline and naphthyridine derivatives and pharmaceutical compositions
ATE150462T1 (de) Pyrazolopyridinverbindungen und verfahren zu ihrer herstellung
NZ240676A (en) Heterocyclic compounds substituted by a (piperidin-4-yl)-1-oxoalkyl group and pharmaceutical compositions thereof
ES2017820A6 (es) Procedimiento de preparacion de un derivado de carboxamida.
HU9603433D0 (en) Novel 4-6-diaryl-pyrimidine-derivatives and salts thereof
DK0474243T3 (da) 1-methylcarbapenemderivater og fremgangsmåde til fremstilling deraf
FI940229A (sv) Tricykliska kondenserade heterocykliska föreningar, deras framställning och användning
ATE142641T1 (de) Neue peptid-verbindungen und verfahren zur herstellung davon
IL75115A (en) 3-oxadiazolyl-beta-carboline derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
FI935800A0 (fi) Antidepressiva och mot Parkisons sjukdom verksamma foereningar
GEP20032928B (en) Halo Derivatives of 9-Deoxo-9a-Aza-9a-Homerythromycin A, Method for its Production, Pharmaceutical Compositions Containing the Same and Their Use for Treatment or Prevention of Bacterial Infections
WO2001022951A3 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis
GB2321459A (en) Synthesis of carboxylic acid derivatives
RU93051079A (ru) Фармацевтические соединения, способ получения, фармацевтическая композиция
GB8907306D0 (en) New compositions of matter
WO1998013349A3 (fr) Heteroaryloxyethylamines en tant que ligands 5-ht¿1a?
IE823036L (en) Azetidinones.